ConductScience.org, home

Trial · NCT04473950

Results by group20

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Delay Discounting of Money Rate (k)Pain GroupNaloxone Session-1.65Standard Deviation 1.17k-value
Delay Discounting of Money Rate (k)No Pain GroupNaloxone Session-2.16Standard Deviation 0.92k-value
Delay Discounting of Money Rate (k)Pain GroupPlacebo Session-1.91Standard Deviation 0.56k-value
Delay Discounting of Money Rate (k)No Pain GroupPlacebo Session-2.11Standard Deviation 1.11k-value
Study Session Peak Pain Visual Analog Scale (VAS)Pain GroupPlacebo25.2Standard Deviation 22.9score on a scale
Study Session Peak Pain Visual Analog Scale (VAS)No Pain GroupPlacebo0Standard Deviation 0score on a scale
Study Session Peak Pain Visual Analog Scale (VAS)Pain GroupNaloxone28.2Standard Deviation 25.4score on a scale
Study Session Peak Pain Visual Analog Scale (VAS)No Pain GroupNaloxone0.25Standard Deviation 0.5score on a scale
Peak Clinical Opiate Withdrawal Scale (COWS) RatingPain GroupPlacebo1.8Standard Deviation 0.98score on a scale
Peak Clinical Opiate Withdrawal Scale (COWS) RatingNo Pain GroupPlacebo2.75Standard Deviation 0.5score on a scale
Peak Clinical Opiate Withdrawal Scale (COWS) RatingPain GroupNaloxone2.5Standard Deviation 2.6score on a scale
Peak Clinical Opiate Withdrawal Scale (COWS) RatingNo Pain GroupNaloxone3Standard Deviation 2.4score on a scale
Peak Subjective Opiate Withdrawal Scale (SOWS) RatingPain GroupPlacebo3.2Standard Deviation 2.6score on a scale
Peak Subjective Opiate Withdrawal Scale (SOWS) RatingNo Pain GroupPlacebo2.8Standard Deviation 2.1score on a scale
Peak Subjective Opiate Withdrawal Scale (SOWS) RatingPain GroupNaloxone2.7Standard Deviation 2.9score on a scale
Peak Subjective Opiate Withdrawal Scale (SOWS) RatingNo Pain GroupNaloxone3.8Standard Deviation 2.1score on a scale
Peak Increase From Baseline Pupil DiameterPain GroupPlacebo0.06Standard Deviation 0.08millimeters
Peak Increase From Baseline Pupil DiameterNo Pain GroupPlacebo0.03Standard Deviation 0.07millimeters
Peak Increase From Baseline Pupil DiameterPain GroupNaloxone0.31Standard Deviation 0.44millimeters
Peak Increase From Baseline Pupil DiameterNo Pain GroupNaloxone0.07Standard Deviation 0.09millimeters

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04473950/results